russjcardiolРоссийский кардиологический журналRussian Journal of Cardiology1560-40712618-7620«SILICEA-POLIGRAF» LLCrussjcardiol-1120Research ArticleОРИГИНАЛЬНЫЕ СТАТЬИORIGINAL ARTICLESАДИПОНЕКТИН И ПОКАЗАТЕЛИ АТЕРОСКЛЕРОТИЧЕСКОГО РЕМОДЕЛИРОВАНИЯ СОННЫХ АРТЕРИЙADIPONECTIN AND ATHEROSCLEROTIC REMODELLING OF CAROTID ARTERIESШевченкоО. П.ShevchenkoO. P.

профессор, зав. кафедрой

esheen@inbox.ruШевченкоА. О.ShevchenkoA. O.

д.м.н., профессор кафедры

esheen@inbox.ruШинЕ. В.ShinE. V.

аспирант кафедры

esheen@inbox.ruТуликовМ. В.TulikovM. V.

врач-кардиолог

esheen@inbox.ruСлесареваЮ. С.SlesarevaYu. S.

аспирант кафедры

esheen@inbox.ruГинзбургЛ. М.GinsburgL. M.

врач-кардиолог

esheen@inbox.ruРГМУ Росздрава, кафедра кардиологии ФУВ, МоскваRussian FederationФГУ Клиническая больница УДП РФ, МоскваRussian FederationЛюберецкая районная больница №1, ЛюберцыRussian Federation201128082011043841Copyright © Шевченко О.П., Шевченко А.О., Шин Е.В., Туликов М.В., Слесарева Ю.С., Гинзбург Л.М., 20112011Шевченко О.П., Шевченко А.О., Шин Е.В., Туликов М.В., Слесарева Ю.С., Гинзбург Л.М.Shevchenko O.P., Shevchenko A.O., Shin E.V., Tulikov M.V., Slesareva Y.S., Ginsburg L.M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://russjcardiol.elpub.ru/jour/article/view/1120

Изучены связи уровней адипонектина и показателей атеросклеротического ремоделирования сонных артерий у 50 больных ишемической болезнью сердца (ИБС). Установлено, что у больных с повышенными уровнями адипонек-тина в крови отмечается меньшая выраженность атеросклероза сонных артерий (достоверно меньше среднее значение показателя суммарного объема атером) и большая эластичность артериальной стенки (характеризующаяся меньшим средним значением показателя жесткости – Icompl), чем в группе пациентов с низкими уровнями адипонектина.

The associations between adiponectin levels and atherosclerotic remodelling of carotid arteries were investigated in 50 patients with coronary heart disease. Among patients with increased adiponectin levels, carotid atherosclerosis was less severe (significantly lower mean values of total plaque volume), while arterial wall elasticity was higher (lower mean values of arterial stiffness, Icompl), compared to individuals with lower adiponectin concentrations.

ишемическая болезнь сердцаадипонектинатеросклероз сонных артерийартериальная жёсткостьCoronary heart diseaseadiponectincarotid artery atherosclerosisarterial stiffnessReferencesDelaigle AM, Jonas JC, Bauche IB, et al. Induction of adiponectin in skeletal muscle by inflammatory cytokines: in vivo and in vitro studies. Endocrinology. 2004; 145: 5589–5597.Delaigle AM, Jonas JC, Bauche IB, et al. Induction of adiponectin in skeletal muscle by inflammatory cytokines: in vivo and in vitro studies. Endocrinology. 2004; 145: 5589–5597.Ferrante G. et al. Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study Eur Heart J (2008) 29(15): 1922-1923.Ferrante G. et al. Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study Eur Heart J (2008) 29(15): 1922-1923.George J, Patal S, Wexler D, et al. Circulating adiponectin concentrations in patients with congestive heart failure. Heart. 2006; 92: 1420–1424.George J, Patal S, Wexler D, et al. Circulating adiponectin concentrations in patients with congestive heart failure. Heart. 2006; 92: 1420–1424.Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005; 26: 439–451.Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005; 26: 439–451.Karbowska J, Kochan Z. Role of adiponectin in the regulation of carbohydrate and lipid metabolism. J Physiol Pharmacol. 2006; 57: 103–113.Karbowska J, Kochan Z. Role of adiponectin in the regulation of carbohydrate and lipid metabolism. J Physiol Pharmacol. 2006; 57: 103–113.Kintscher U. Does adiponectin resistance exist in chronic heart failure? Eur Heart J. 2007; 28: 1676–1677.Kintscher U. Does adiponectin resistance exist in chronic heart failure? Eur Heart J. 2007; 28: 1676–1677.Kistorp C, Faber J, Galatius S, et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation. 2005; 112: 1756–1762.Kistorp C, Faber J, Galatius S, et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation. 2005; 112: 1756–1762.Lyon CJ, Law RE, Hsueh WA. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology. 2003; 144: 2195–2200.Lyon CJ, Law RE, Hsueh WA. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology. 2003; 144: 2195–2200.McEntegart MB, Awede B, Petrie MC, et al. Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide. Eur Heart J. 2007; 28: 829–835.McEntegart MB, Awede B, Petrie MC, et al. Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide. Eur Heart J. 2007; 28: 829–835.Norrelund H, Wiggers H, Halbirk M, et al. Abnormalities of whole body protein turnover, muscle metabolism and levels of metabolic hormones in patients with chronic heart failure. J Intern Med. 2006; 260: 11–21.Norrelund H, Wiggers H, Halbirk M, et al. Abnormalities of whole body protein turnover, muscle metabolism and levels of metabolic hormones in patients with chronic heart failure. J Intern Med. 2006; 260: 11–21.Pineiro R, Iglesias MJ, Gallego R, et al. Adiponectin is synthesized and secreted by human and murine cardiomyocytes. FEBS Lett. 2005; 579: 5163–5169.Pineiro R, Iglesias MJ, Gallego R, et al. Adiponectin is synthesized and secreted by human and murine cardiomyocytes. FEBS Lett. 2005; 579: 5163–5169.Skurk C, Wittchen F, Suckau L, et al. Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy. Eur Heart J. 2008; 29: 1168–1180.Skurk C, Wittchen F, Suckau L, et al. Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy. Eur Heart J. 2008; 29: 1168–1180.Tamura T, Furukawa Y, Taniguchi R, et al. Serum adiponectin level as an independent predictor of mortality in patients with congestive heart failure. Circ J. 2007; 71: 623–630.Tamura T, Furukawa Y, Taniguchi R, et al. Serum adiponectin level as an independent predictor of mortality in patients with congestive heart failure. Circ J. 2007; 71: 623–630.Tanaka T, Tsutamoto T, Sakai H, et al. Effect of atrial natriuretic peptide on adiponectin in patients with heart failure. Eur J Heart Fail. 2008; 10: 360–366.Tanaka T, Tsutamoto T, Sakai H, et al. Effect of atrial natriuretic peptide on adiponectin in patients with heart failure. Eur J Heart Fail. 2008; 10: 360–366.Tsutamoto T, Tanaka T, Sakai H, et al. Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure. Eur Heart J. 2007; 28: 1723–1730.Tsutamoto T, Tanaka T, Sakai H, et al. Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure. Eur Heart J. 2007; 28: 1723–1730.

The authors declare that there are no conflicts of interest present.